Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2025-12-25 @ 2:30 AM
NCT ID:
NCT07190534
Eligibility Criteria:
Inclusion Criteria:
* Age 18 years or older
* Diagnosis of frontal fibrosing alopecia (FFA)
* Willing and able to provide written informed consent
* Adequate understanding of the Dutch language
* No known contraindications or allergies to hydroxychloroquine (HCQ) or methotrexate (MTX)
Exclusion Criteria:
* Histopathological different diagnosis than FFA.
* Inability to adhere to the study protocol, including medication intake, clinic visits, and questionnaire completion.
* Patients who are ineligible for the HCQ arm (due to contraindications), are automatically included in the MTX arm.
Contraindications HCQ: retinopathy and/or maculopathy/myasthenia gravis/body weight less than 35 kg
\- Patients who are ineligible for the MTX arm (due to contraindications), are automatically included in the HCQ arm.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07190534
Study Brief:
Protocol Section:
NCT07190534